Activation of AMPK enhances insulin sensitivity, inhibits hepatic lipid synthesis, and promotes fatty acid oxidation, thereby helping to mitigate the progression of MASLD (39). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.